- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Astec LifeSciences Limited has announced a board meeting on 28th March, 2025, to seek shareholder approval via postal ballot for appointing Mr. Burjis Nadir Godrej as Managing Director for a five-year term, starting April 1, 2025, without remuneration. This strategic move, backed by the Nomination and Remuneration Committee’s recommendation, aims to leverage Mr. Godrej's expertise, given his role as a Non-Executive Director since July 2022. Investors may view this as a potential opportunity, given the leadership continuity and Mr. Godrej's qualifications, including an MBA from Harvard, enhancing long-term governance.